financetom
Business
financetom
/
Business
/
China-based Canadian stole Tesla secrets, say US prosecutors
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
China-based Canadian stole Tesla secrets, say US prosecutors
Mar 19, 2024 3:31 PM

NEW YORK, March 19 (Reuters) - A Canadian resident of

China has been arrested in the United States for allegedly

stealing electric car manufacturer Tesla's trade

secrets and conspiring to sell them to undercover law

enforcement officers.

Klaus Pflugbeil, the operator of a China-based business that

sells technology used in electric vehicles, was arrested on

Tuesday in New York, federal prosecutors in Brooklyn said.

He had traveled for a meeting with undercover agents whom he

had believed were Long Island businesspeople, prosecutors said.

Pflugbeil and business partner Yilong Shao built their

business using trade secrets belonging to "a leading U.S.-based

electric vehicle company," prosecutors said. Shao was also

charged but remained at large.

Prosecutors did not name the U.S.-based company, but said it

acquired a Canada-based manufacturer of battery assembly lines

in 2019. That matches the description of Tesla's acquisition of

a Canadian company named Hibar.

Both Pflugbeil and Shao are former employees of the Canadian

company, prosecutors said.

Pflugbeil was expected to make an initial appearance in

Brooklyn federal court on Tuesday afternoon, prosecutors said.

His lawyer did not immediately respond to a request for comment.

Shao could not be reached for comment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Grupo Aeroportuario del Sureste's August Passenger Traffic Ticks Up
Grupo Aeroportuario del Sureste's August Passenger Traffic Ticks Up
Sep 8, 2025
05:06 PM EDT, 09/08/2025 (MT Newswires) -- Grupo Aeroportuario del Sureste (ASR) reported late Monday passenger traffic grew 0.6% to 6.0 million passengers in August from a year earlier. Passenger traffic increased 4.6% in Puerto Rico and 2.7% in Colombia, and fell 1.6% in Mexico, the airport operator said. ...
Nelnet Insider Sold Shares Worth $1,056,219, According to a Recent SEC Filing
Nelnet Insider Sold Shares Worth $1,056,219, According to a Recent SEC Filing
Sep 8, 2025
05:06 PM EDT, 09/08/2025 (MT Newswires) -- Thomas Edward Henning, Director, on September 05, 2025, sold 8,196 shares in Nelnet ( NNI ) for $1,056,219. Following the Form 4 filing with the SEC, Henning has control over a total of 11,058 Class A common shares of the company, with 11,058 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1258602/000100888625000259/xslF345X05/form4.xml ...
BRP Shareholder Bain Capital to Sell 1.5 Million Shares in Bought Deal
BRP Shareholder Bain Capital to Sell 1.5 Million Shares in Bought Deal
Sep 8, 2025
05:09 PM EDT, 09/08/2025 (MT Newswires) -- BRP (DOO.TO, DOOO) was last seen down 2.4% in after-hours Nasdaq trading after on Monday saying Bain Capital Integral Investors II will sell 1.5-million of BRP's subordinate voting shares priced at C$90.71 per share in a secondary offering. BRP is not selling any shares and will not receive any proceeds, the company added....
Ultragenyx Pharmaceutical Reports Positive Phase 3 Data on Rare Metabolic Disorder Treatment
Ultragenyx Pharmaceutical Reports Positive Phase 3 Data on Rare Metabolic Disorder Treatment
Sep 8, 2025
05:02 PM EDT, 09/08/2025 (MT Newswires) -- Ultragenyx Pharmaceutical ( RARE ) reported positive longer-term results from its Phase 3 study of a gene therapy developed to treat glycogen storage disease type Ia, a rare and life-threatening metabolic disorder. The investigational therapy DTX401 led to further reductions in patients' reliance on cornstarch supplements at week 96, while maintaining stable blood...
Copyright 2023-2026 - www.financetom.com All Rights Reserved